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Introduction
Pyoderma gangrenosum is a rare chronic skin disease re-
sulting in extensive ulceration and extremely uncommon in 
pregnancy. It is typically known to affect the lower limbs, 
but several cases have been reported occurring after minor 
trauma or surgical procedure. Numerous systemic disorders 
have been described to be associated, including inflammatory 
bower disease, rheumatologic arthritis, antiphospholipid an-
tibody syndrome, or hematological malignancy [1]. Pyoderma 
gangrenosum is characterized by extensive pustular lesion 
that rapidly progresses to painful ulcers with undermined vio-
laceous borders. The diagnosis is mainly based on the clinical 
manifestation and is confirmed through exclusion of other 
causes of cutaneous diseases. 
We present a challenging case of successful vaginal delivery 
with pyoderma gangrenosum which developed after prior 
cesarean section and failed to improve with subsequent anti-
biotic therapy. 
Case report
A 33-year-old woman with parity 1-0-2-1, was referred to ob-
stetric department for early pregnancy in October 2013. She 
has been diagnosed as pyoderma gangrenosum and had a 
history of admission to dermatology department of Seoul Na-
tional University hospital from July 1st to August 3rd in 2012. 
Her dermatologist sent her to obstetric department for con-
sultation of antenatal management immediately after recogni-
tion of current pregnancy. At her first office based visit, trans-
vaginal ultrasound examination was performed and normal 
intrauterine pregnancy was confirmed. Estimated gestation 
age was about 7 weeks. 
Thorough history taking and record review were followed. 
In June of 2011, she delivered a healthy female child at term 
by emergency cesarean section with lower uterine segment 
transverse incision due to premature rupture of membrane 
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and alleged placenta previa totalis at a local clinic. The surgical 
procedure was uneventful. After 1 week, skin wound showed 
dehiscence with purulent discharge and painful induration. 
Wound culture was done and antibiotics (ceftezol, amikacin, 
and metronidazole) were given. Careful wound dressing was 
performed twice daily. On postoperative day 9, debridement 
and closure of wound were done, however wound dehiscence 
was found again and pain was aggravated. The previous 
wound culture showed no growth of bacteria, but the clini-
cian changed antibiotics to ertapenem and clindamycin.
The condition of wound did not appear to be improved 
and serial follow-ups of wound culture resulted in no bacte-
rial growth. Her vital signs including body temperature were 
normal. Wound dressing was done twice daily with saline ir-
rigation. Wound tissue was obtained and the result of biopsy 
was supprative inflammation with fibrinoid vascular necrosis, 
consistent with abscess. The clinician changed antibiotics 
three times more and all the antibiotics that she had been 
received are listed in Table 1. On postoperative day 24, urine 
output started to decrease remarkably and creatinine level 
was reached to 4.9 mg/dL. Finally she was referred to Seoul 
National University Hospital for the management of acute re-
nal failure. 
On July 1st of 2011, she was admitted to dermatology depart-
ment. Extensive painful ulcerative open wound with erythema-
tous plaques and violaceous colored border involved the whole 
lower abdomen (Fig. 1A, B). Tenderness was found around 
wound margins. Vital signs of the patient including body 
temperature were normal. Her blood test revealed remarkable 
increase in creatinine (5.3 mg/dL) and C-reactive protein (16.97 
mg/dL). To check urine output effectively, Foley catheter was 
inserted and enough hydration through intravenous line was 
Fig. 1. (A,B) Cesarean delivery wound before treatment for pyoderma gangrenosum on 1st day of admission. (C) Appearance of wound 
on 13th day of hospitalization. (D) Appearance of wound after complete healing.
A  B
C  D
Table 1. Antibiotics administered at the prior hospital 
Antibiotics Period of administration
Ceftezol+amikacin+metronidazole 2011-06-09 to 2011-06-12
Ertapenem+clindamycin 2011-06-13 to 2011-06-14
Ertapenem 2011-06-15 to 2011-06-16
Ampicillin/sulbactam 2011-06-17 to 2011-06-20
Vancomycin+tazocin 2011-06-21 to 2011-06-27
Teicoplanin+tazocin 2011-06-28 to 2011-07-01
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followed. Nephrologists recommended to use ceftriaxone only 
for antibiotics and stop all other medications that could cause 
nephrotoxicity. Kidney ultrasound showed no hydronephrosis, 
but increased echogenicity and decreased vascularity for both 
sides. Acute kidney injury caused by several antibiotics was 
highly suspected. 
Dermatologists suspected pyoderma gangrenosum for the 
first site since there had been no improvement on several 
antibiotics used in previous hospital and biopsy result had 
confirmed chronic granulation tissue rather than acute in-
fection site. They decided to use prednisolone with careful 
attention on renal function, starting at 70 mg daily. Cyclo-
sporin was not given because of nephrotoxicity. In addition, 
evaluation for other systemic diseases such as antiphospho-
lipid syndrome, rheumatologic diseases, and inflammatory 
bowel disorders was performed. Lupus erythematous cell 
antibody, anti-double-stranded DNA, rheumatoid factor and 
fluorescent antinuclear antibody were all negative, although 
antiphospholipid antigen was found to be weakly positive. 
Endoscopic gastroduodenoscopy and colonoscopy showed 
no sign of inflammatory bowel disorder, but mild erosion 
only.
Consultation to plastic surgery department was done during 
admission for consideration of skin graft. After thorough dis-
cussion, doctors determined not to perform skin graft opera-
tion for several reasons. First of all, there was strong possibility 
that the graft donor site might develop pyoderma gangreno-
sum as well. Continued use of steroid was another risk of vul-
nerability to acute infection or other complications of surgery. 
Therefore, only silver foam dressing and methylprednisolone 
ointment were applied without any surgical intervention.   
On her hospital day 5, creatinine fell down to 3.51 mg/dL 
and C-reactive protein was 1.93 mg/dL. From 16th day of 
hospitalization, her creatinine was under 1.00 mg/dL and C-
reactive protein was checked under 0.5 mg/dL. The wound 
responded dramatically to prednisolone. No more discharge 
came out of the wound and healing started from recession of 
erythermatous margin (Fig. 1C). She was discharged from hos-
pital with oral antibiotics in addition to prednisolone tapered 
to 40 mg and office based follow-ups with regular dressing 
were done with tapering steroid. After one month, synergistic 
cyclosporine was started at 150 mg daily, increasing to 200 
mg daily 24 days later. At the same time, prednisolone was 
lowered to 7.5 mg. She took 100 mg of cyclosporine only 
since January 2012 until she decided to prepare for next preg-
nancy. 
For current pregnancy, she regularly visited obstetric depart-
ment and routine antenatal check-ups were performed. She 
presented with gross rupture of membranes at 35 weeks 
and 5 days gestational age. Cervical dilatation was 1 cm and 
uterine contraction was irregular. The previous wound from 
pyoderma gangrenosum was found to be perfectly healed 
with fibrinotic skin formation (Fig. 1D). After observation at 
ward for one week with intravenous antibiotics, labor pain 
developed at 36 weeks and 4 days of gestation and augmen-
tation with careful use of intravenous oxytocin was applied. A 
healthy female baby of 2,300 g was delivered through vaginal 
vacuum extracted delivery with an Apgar score of 9. Without 
any complication, she was discharged with her baby on post-
partum day 2. 
Discussion
Negative wound cultures and the worsening of condition de-
spite of antibiotics indicated an inflammatory process, not an 
acute infection by microbiologic causes. The diagnosis of pyo-
derma gangrenosum could be supported by rapid response 
to steroid therapy. For an obstetrician, who rarely experiences 
this disease, the diagnosis could be mistaken for an acute 
wound infection and easily missed to be properly managed. 
Even though pyoderma gangrenosum is an extremely rare 
disease, suspicion of the diagnosis in cases of vigorous and ex-
tensive wound infection unresponsive to antibiotics should be 
considered since appropriate therapy including corticosteroids 
or cyclosporine usually improves the wound dramatically. To 
avoid another disasterous wound, we performed vaginal deliv-
ery after cesarean section for above patient and it ended suc-
cessfully. This is a unique case for pregnancy with pyoderma 
gangrenosum. 
Pyoderma gangrenosum is extremely uncommon noninfec-
tious neutrophilic dermatoses. Majority of cases develop for 
the age group of 20 to 50 years, with women being more 
frequently affected than men [1]. Lesions can develop after 
surgery or even minor trauma, sometimes even spontane-
ously. The typical presentation is the wide extension of wound 
with an erythematous papule or pustule that forms purulent 
discharge as well as protruding borders spreading peripherally. 
The etiology is not fully understood and the literatures pub-
lished about its occurrence during pregnancy are extremely 
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rare. Because it has been known to be commonly associated 
with systemic diseases, pregnancy as a state of immunosup-
pression state may contribute to the manifestation of pyo-
derma gangrenosum. 
In addition to correct diagnosis and treatment, investigation 
for other associated systemic diseases such as systemic lupus 
erhythematous, inflammatory bowel disease, rheumatoid ar-
thritis, antiphospholipid antibody syndrome, and hematologic 
malignancies is essential [2]. Some expertss also recommend 
screening for human immunodeficiency virus since there have 
been more than five cases reporting pyoderma gangrenosum 
related to human immunodeficiency virus infection [3]. This 
patient underwent above evaluation and showed none of 
them was associated. 
For wound management, local therapy with gentle saline 
dressings and steroid ointment is adequate. Unlike wound 
infection, systemic treatment for pyoderma gangrenosum 
mainly consists of immune modulation and the use of cortico-
steroids. Corticosteroids, such as prednisolone, 1 to 2 mg per 
kg daily, are commonly used for initial therapy. Immunosup-
pressive therapy with cyclosporine has become an accepted 
adjuvant treatment [4]. Dapsone (diaminodiphenylsulfone), a 
drug for leprosy, is another commonly used medication with 
combination of steroids [5].
There are several alternative treatment options studied. 
Infliximab in a single dose of 5 mg/kg given daily has been 
recently shown to be effective. Intralesional cyclosporine and 
azathioprine have been studied, however the results revealed 
various range of improvement [6]. Autologous skin graft can 
be considered for wide lesion, but it may flare up the disease 
at the donor site. Use of bioengineered skin is still experimen-
tal [7].
Making no traumatic lesion is the best method of prevention 
and therefore, trial of vaginal delivery should be considered for 
patients with alleged pyoderma gangrenosum in pregnancy if 
there is no absolute indication for cesarean section. 
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